Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Peri-implantitis Market Size, Share & Trends Analysis by Method Type and Region, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030.
The success rate of dental implants was reported to be 92%-98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.
Peri-implantitis Market Report: Highlights
- The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
- Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
- Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment
- In the Asia-Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes
Report Attribute | Details |
No. of Pages | 100 |
Forecast Period | 2024-2030 |
Estimated Market Value (USD) in 2024 | $1.04 Billion |
Forecasted Market Value (USD) by 2030 | $1.75 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Peri-implantitis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter's Five Forces Analysis
3.3.2. PESTLE Analysis
Chapter 4. Peri-implantitis Market: Method Type Business Analysis
4.1. Method Type Market Share, 2024 & 2030
4.2. Method Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Method Type, 2018 to 2030 (USD Billion)
4.4. Surgical
4.4.1. Surgical Market, 2018-2030 (USD Billion)
4.4.2. Bone Regeneration
4.4.3. Open Flap Debridement
4.4.4. Implantoplasty
4.5. Non-surgical
4.5.1. Non-surgical Market, 2018-2030 (USD Billion)
4.5.2. Mechanical Debridement
4.5.3. Laser Debridement
4.5.4. Antibiotics
4.5.5. Others
Chapter 5. Peri-implantitis Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
5.4. North America
5.5. Europe
5.6. Asia-Pacific
5.7. Latin America
5.8. MEA
Chapter 6. Competitive Landscape
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Pfizer Inc.
6.5.2. Cadila Pharmaceuticals
6.5.3. GaronitPharma
6.5.4. Basic Pharma Life Science Pvt Ltd.
6.5.5. Prachi Pharmaceuticals Private Limited
6.5.6. Geistlich Pharma India Pvt. Ltd.
6.5.7. Healthy Life Pharma Private Limited
6.5.8. Zimmer Biomet
6.5.9. Institut Straumann AG
6.5.10. Dentsply Sirona
For more information about this report visit https://www.researchandmarkets.com/r/sy502t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
